Why the study?
Does surgery plus chemotherapy improve survival in patients with small intestinal angiosarcoma compared to surgery alone?
Population
Patients with small bowel angiosarcoma, median age 68.5 years, male to female ratio 1.6:1.
Comparison
Surgery plus chemotherapy vs Surgical resection alone
Design
Review
Authors
Loading...
Should not yet change practice for small intestinal angiosarcoma; leaves open adjuvant chemotherapy benefit pending prospective trials.
Does surgery plus chemotherapy improve survival in patients with small intestinal angiosarcoma compared to surgery alone?
In patients with rare small intestinal angiosarcoma, combining surgery with chemotherapy may significantly prolong survival compared to surgery alone.
Nai et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: